unknown by Carl Deetz et al.
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessPoster presentation
Rapid Activation of an Effector Phenotype in Human Vγ2/Vδ2 T 
Cells Stimulated With a Toll-Like Receptor 2 (Tlr2) Agonist
Carl Deetz*‡, Andrew Hebbeler, Ilia Tikhonov, Cristiana Cairo, Jean-
Saville Cummings and C David Pauza
Address: Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, MD 21201
* Corresponding author    ‡Presenting author    
Approximately 1–10% of circulating CD3+ cells in the
blood express the gamma delta (γδ) T cell receptor (TCR)
and, of these γδ T cells, the majority express the Vγ2/Vδ2
receptor. In HIV-infection, there is a targeted destruction
of Vγ2-Jγ1.2/Vδ2+ T cells. This is the only TCR-specific
change common to all individuals infected with HIV.
Because Vγ2/Vδ2 are potently cytotoxic for tumor cells,
loss of these cells may be part of the mechanism that pro-
motes AIDs-related malignancies. Tumor recognition by
γδ T cells may require a 60 kDa heat shock protein
(HSP60) on Daudi Burkitt's lymphoma cells. However,
HSP60 recognition may not be mediated by the TCR but
by another receptor on γδ T cells. Since γδ T cells also
respond to microbial infection, this additional activatory
receptor may be in the toll-like family of receptors that
recognize pathogen-associated molecular patterns. To
explore this recognition, we treated isopentenyl pyro-
phosphate (IPP) expanded Vγ2/Vδ2 with the TLR2 agonist
PAM3Cys and analyzed the activation of an effector phe-
notype by measuring IFN-γ secretion and cell killing.
Daudi cell killing appears to be enhanced by the addition
of the TLR2 agonist. Intracellular staining of γδ T cells after
a two-hour incubation with PAM3Cys and anti-γδ TCR
antibody revealed as much as a ten-fold increase in IFN-g
over that produced by anti-γδ TCR antibody stimulation
alone. Therefore, it seems that TLR2 does play a role in
Daudi cell killing and signaling through this receptor
works synergistically with TCR signaling to induce an
early TH1-type immune response by IFN-γ production.
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